Respirerx Pharmaceuticals Inc.
Glen Rock, NJ Part of Cortex Pharmaceuticals Inc (DE
- UEI
- HWS8C3MQDTH7
- CAGE
- 70D17
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- Corporate family
-
-
Cortex Pharmaceuticals Inc (DE
Parent
E3J6AGKN6MN3
- Respirerx Pharmaceuticals Inc. HWS8C3MQDTH7
-
Cortex Pharmaceuticals Inc (DE
Parent
E3J6AGKN6MN3
- SAM.gov registration date
- Physical address
- 126 Valley Rd c, Glen Rock, NJ 07452, USA
- Website
- respirerx.com
- Founded
- 1987
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of a novel, preferring potentiator of gabaa receptor for treatment of epilepsy - project summary epilepsy is… | National Institute of Neurological Disorders and Stroke | $2,999,738 | |
| : novel treatment for drug-induced respiratory depression. September 18, 2014 - march 17, 2015. N43DA-14-2239. | National Institute on Drug Abuse | $148,583 |
Quick answers
What is Respirerx Pharmaceuticals Inc.'s UEI?
Respirerx Pharmaceuticals Inc.'s Unique Entity ID (UEI) in SAM.gov is HWS8C3MQDTH7.
What is Respirerx Pharmaceuticals Inc.'s CAGE code?
Respirerx Pharmaceuticals Inc.'s CAGE code is 70D17.
What is Respirerx Pharmaceuticals Inc.'s primary NAICS code?
Respirerx Pharmaceuticals Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Respirerx Pharmaceuticals Inc. located?
Respirerx Pharmaceuticals Inc.'s physical address in SAM.gov is 126 Valley Rd c, Glen Rock, NJ 07452, USA.
Is Respirerx Pharmaceuticals Inc. registered in SAM.gov?
Yes. Respirerx Pharmaceuticals Inc.'s SAM.gov registration is active through November 12, 2026.
Who is Respirerx Pharmaceuticals Inc.'s parent company?
Respirerx Pharmaceuticals Inc. is part of Cortex Pharmaceuticals Inc (DE.
What is Respirerx Pharmaceuticals Inc.'s most recent federal award?
Respirerx Pharmaceuticals Inc.'s most recent federal grant award is Development of a novel, preferring potentiator of gabaa receptor for treatment of epilepsy - project summary epilepsy is… (R44NS143576), from National Institute of Neurological Disorders and Stroke, on September 23, 2025.
On GovTribe
See Respirerx Pharmaceuticals Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors